Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
or

Tonix Pharm Holdings (TNXP)

Tonix Pharm Holdings (TNXP)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
17.82 +0.63 (+3.66%) 04/25/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 17.36 -0.46 (-2.58%) 19:53 ET
Quote Overview for Fri, Apr 25th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
16.83
Day High
18.74
Open 17.05
Previous Close 17.19 17.19
Volume 808,800 808,800
Avg Vol 936,165 936,165
Stochastic %K 38.97% 38.97%
Weighted Alpha -81.03 -81.03
5-Day Change +2.11 (+13.43%) +2.11 (+13.43%)
52-Week Range 6.76 - 672.00 6.76 - 672.00
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 110,616
  • Shares Outstanding, K 6,435
  • Annual Sales, $ 10,090 K
  • Annual Income, $ -130,040 K
  • EBIT $ -137 M
  • EBITDA $ -132 M
  • 60-Month Beta 1.50
  • Price/Sales 10.85
  • Price/Cash Flow N/A
  • Price/Book 0.53

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -3.23
  • Number of Estimates 2
  • High Estimate -3.09
  • Low Estimate -3.37
  • Prior Year -575.08
  • Growth Rate Est. (year over year) +99.44%

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.21 +25.40%
on 04/07/25
Period Open: 29.77
31.87 -44.08%
on 03/26/25
-11.95 (-40.14%)
since 03/25/25
3-Month
6.76 +163.61%
on 03/04/25
Period Open: 38.31
58.30 -69.43%
on 01/28/25
-20.49 (-53.48%)
since 01/24/25
52-Week
6.76 +163.61%
on 03/04/25
Period Open: 512.00
672.00 -97.35%
on 05/17/24
-494.18 (-96.52%)
since 04/25/24

Most Recent Stories

More News
Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress Washington 2025

TNXP : 17.82 (+3.66%)
Tonix Pharmaceuticals Announces Oral Presentation and Panel Participation at the World Vaccine Congress Washington 2025

TNXP : 17.82 (+3.66%)
Tonix Pharmaceuticals and Makana Therapeutics Announce Collaboration Combining Tonix’s Anti-CD40L Monoclonal Antibody (TNX-1500) with Makana’s Genetically Engineered Organs in Preclinical and Clinical Xenotransplantation Studies

TNXP : 17.82 (+3.66%)
Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting

TNXP : 17.82 (+3.66%)
Tonix Pharmaceuticals to Present at the 2025 Jones Trading Healthcare and Innovation Conference

TNXP : 17.82 (+3.66%)
Tonix Pharmaceuticals Launches TONIX ONEâ„¢, a Fully-Integrated Digital Platform Designed to Help Patients Better Understand and Manage Their Migraine Condition

TNXP : 17.82 (+3.66%)
Tonix’s Experimental Non-Opioid Analgesic Treatment for Fibromyalgia Could Start Bringing Relief Later This Year

CHATHAM, NEW JERSEY / ACCESS Newswire / March 31, 2025 / This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding Corp. with...

TNXP : 17.82 (+3.66%)
New to The Street Show #639 Premieres Nationwide on Bloomberg Television, March 29 at 6:30 PM EST Featuring BioVie, Roadzen, Tonix Pharma, and eXoZymes Inc.

Sponsored by The Sustainable Green Team (OTC: SGTM), featuring Kevin Harrington - the ORIGINAL Shark from Shark Tank

RDZN : 0.9110 (+3.17%)
BIVI : 0.8400 (-6.06%)
TNXP : 17.82 (+3.66%)
SGTM : 0.0754 (+0.53%)
Tonix Pharmaceuticals Announces Presentation at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting

TNXP : 17.82 (+3.66%)
Pharma Frenzy: Volatility Ignites Biotech Sector

Two biotech companies have surged on recent developments, illustrating biotech's volatility and prompting investors to evaluate potential long-term value.

TNXP : 17.82 (+3.66%)
LXEO : 3.68 (+0.27%)

Business Summary

Tonix Pharmaceuticals Holding Corp. is a specialty pharmaceutical company focused on developing new pharmaceutical products for CNS conditions. The Company develops therapies for disorders that include fibromyalgia syndrome and post-traumatic stress disorder. Its lead product candidates include TNX-102,...

See More

Key Turning Points

3rd Resistance Point 20.67
2nd Resistance Point 19.71
1st Resistance Point 18.76
Last Price 17.82
1st Support Level 16.85
2nd Support Level 15.89
3rd Support Level 14.94

See More

52-Week High 672.00
Fibonacci 61.8% 417.88
Fibonacci 50% 339.38
Fibonacci 38.2% 260.88
Last Price 17.82
52-Week Low 6.76

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective